Maurie Stang

Non-Executive Chairman

Mr Stang was Executive Director and Chairman of Nanosonics Limited from 14 November 2000 to March 2007. He has been Non-Executive Director and Chairman since March 2007. Mr Stang co-founded and is a director of a number of leading healthcare distribution and biotechnology companies. His business activities and experience span the successful commercialisation of intellectual property across global markets. He has a track record of launching and commercialising a broad range of medical and dental devices worldwide.

Richard England FCA, MAICD

Non-Executive Director

Mr England joined the Board in February 2010. He is a chartered accountant and professional Non-executive Director. Mr England has been a director of Macquarie Atlas Roads Limited (ASX:MQA) since June 2010 and a director of Japara Healthcare Limited (ASX:JHC) since April 2014. In August 2016 Mr England was appointed director and Chairman of QANTM Intellectual Property Ltd (ASX:QIP). He was a director and Chairman of Chandler Macleod Group Limited (ASX:CMG) from February 2008 to April 2015 and a director and Chairman of Ruralco Holdings Limited (ASX:RHL) from 2002 to September 2016.

David Fisher BRurSc (Hons), MAppFin, PhD, FFin, GAICD

Non-Executive Director

Dr Fisher has been a member of the Board since July 2001. Dr Fisher is a founding partner of Brandon Capital Partners, a leading Australian venture capital provider. He has more than 25 years’ extensive operating experience in the biotechnology and healthcare industry in Australia and overseas. He held senior positions with Pharmacia AB (now part of Pfizer, Inc) and was CEO of Peptech Limited (now part of Cephalon Inc. (Nasdaq:CEPH). He was a director of Aeris Environmental Ltd (ASX:AEI) from May 2011 to July 2014.

Michael Kavanagh BSc, MBA (Advanced)

CEO & President

Mr Michael Kavanagh joined Nanosonics as CEO & President effective 21st October 2013.  Michael is a highly experienced executive with over 20 years of international commercial experience in the healthcare market having held local, regional and global roles in Medical Device and Pharmaceutical industries. He holds a BSc Degree from University College Dublin and an MBA (Advanced) from the University of Queensland. Before joining Nanosonics, Michael was Senior Vice President of Global Marketing for the major medical device company Cochlear Limited, a position he held for more than 10 years.

Steven Sargent BBus, FAICD

Non-Executive Director

Mr Sargent joined the Board in July 2016. He has extensive executive experience, having worked across a range of industries spanning the US, Europe and Asia Pacific. Mr Sargent joined GE Capital in in 1993 and was appointed Vice President and Officer of General Electric Company in 2008 and was a member of GE’s Global Corporate Executive Council. Prior to his retirement from GE, Mr Sargent was President and Chief Executive Officer of GE Mining, GE's global mining technology and services business.

Mr Sargent has been a director of Origin Energy Limited (ASX:ORG) since May 2015. He is also a director of the Great Barrier Reef Foundation and Chairman of The Origin Foundation. Previously, Mr Sargent was a director of Veda Group Limited (ASX:VED) from March 2015 to March 2016, a director of Bond University Limited and was on the board of the Business Council of Australia.

Marie McDonald BSc (Hons), LLB (Hons)

Non-Executive Director

Ms McDonald joined the Nanosonics Board in October 2016, bringing with her a strong background in corporate and commercial law having practised for many years as a partner at Ashurst. Ms McDonald has been Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia (2012 to 2013) and was a member of the Australian Takeovers Panel from 2001 to 2010. Ms McDonald is currently a Non-Executive Director of CSL Limited and the Walter and Eliza Hall Institute of Medical Research.